Login
$OPRT
$9.77 +$0.21 (2.2%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Assets
Cash and cash equivalents
Restricted cash
Interest and fees receivable, net
Credit cards receivable held for sale
Loans receivable at fair value
Capitalized software and other intangibles, net
Right of use assets - operating
Other assets
Total assets
Liabilities and stockholders' equity
Liabilities
Secured financing
Asset-backed notes at fair value
Asset-backed borrowings at amortized cost
Corporate financing
Lease liabilities
Other liabilities
Total liabilities
Stockholders' equity
Common stock, $0.0001 par value - 1,000,000,000 shares authorized at June 30, 2026 and December 31, 2025; 46,222,056 shares issued and 45,950,033 shares outstanding at June 30, 2026; 44,709,065 shares issued and 44,437,042 shares outstanding at December 31, 2025
Common stock, additional paid-in capital
Accumulated deficit
Treasury stock at cost, 272,023 shares at June 30, 2026 and December 31, 2025
Total stockholders’ equity
Total liabilities and stockholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support